SUBSCRIBE
SUBSCRIBE

Approvals

FDA
Treatment For Drug-Resistant HIV Developed
August 3, 2006
 · 
1 min read
FDA
FDA Approves Influenza Vaccines To Be Manufactured For Upcoming Flu Season
August 3, 2006
 · 
1 min read
Drug Development
The Day In Review: Pozen, Inc. Inks Pain Deal With AstraZeneca PLC
August 3, 2006
 · 
1 min read
FDA
A Look At Humira From Abbott
August 3, 2006
 · 
1 min read
Business
The Day In Review: Nuvelo, Inc. Expands Archemix Corporation Deal
August 1, 2006
 · 
1 min read
FDA
FDA OKs Pearly Pigments To Color Pills
July 21, 2006
 · 
1 min read
FDA
Snail Venom Painkiller Launched
July 10, 2006
 · 
1 min read
FDA
ImClone Systems And ImClone Systems Release: FDA Approves ERBITUX(R) For Treatment Of Head And Neck Cancer; First And Only Approved Monoclonal Antibody For Squamous Cell Carcinoma Of The Head And Neck
March 1, 2006
 · 
1 min read
FDA
FDA Approves Health Claim For Barley
December 28, 2005
 · 
3 min read
FDA
Lyrica Relieves Diabetes Pain
October 19, 2005
 · 
1 min read
Load More
PRESS RELEASES
FDA
FDA Approves New Option to Treat Heavy Menstrual Bleeding Associated with Fibroids in Women
May 29, 2020
 · 
4 min read
FDA
Menlo Therapeutics Receives FDA Approval of ZILXI™ (minocycline) topical foam, 1.5%, the First Topical Minocycline Treatment for Rosacea
May 29, 2020
 · 
9 min read
FDA
Menlo Therapeutics Receives FDA Approval of ZILXI™ (minocycline) topical foam, 1.5%, the First Topical Minocycline Treatment for RosaceaZILXI™ Now Approved for Inflammatory Lesions of Rosacea in Adults
May 29, 2020
 · 
9 min read
FDA
Immune-Onc Therapeutics IND Application for First-In-Human Trial of IO-202, a Novel Antibody for the Treatment of Acute Myeloid Leukemia, Receives FDA Clearance
May 29, 2020
 · 
3 min read
FDA
Lilly Receives U.S. FDA Approval of TAUVID™ (flortaucipir F 18 injection) for Use in Patients Being Evaluated for Alzheimer’s Disease
May 28, 2020
 · 
10 min read
FDA
FDA Approves First Drug to Image Tau Pathology in Patients Being Evaluated for Alzheimer’s Disease
May 28, 2020
 · 
4 min read
FDA
Gynesonics Receives FDA Clearance to Market Next Generation Sonata® System 2.1
May 28, 2020
 · 
3 min read
Drug Development
Ashvattha Therapeutics Subsidiary Orpheris Announces FDA Agreement to Initiate Phase 2 Study Evaluating OP-101 in Severe COVID-19 Patients
May 28, 2020
 · 
3 min read
FDA
Rebif® U.S. Label Now Includes Pregnancy Outcomes and Lactation Information to Help Inform Treatment Decisions for Women with MS
May 27, 2020
 · 
8 min read
FDA
FDA Approves VESIcare LS™ (solifenacin succinate) Oral Suspension for Pediatric Patients
May 27, 2020
 · 
4 min read
FDA
Centinel Spine Announces FDA Approval for the Manufacturing Transfer of prodisc® Technology
May 27, 2020
 · 
3 min read
FDA
Azitra Announces Rare Pediatric Disease Designation for ATR-12 for the Treatment of Netherton Syndrome
May 27, 2020
 · 
3 min read
FDA
Imaging Endpoints Supports FDA Approvals For Two New Cancer Treatments
May 27, 2020
 · 
2 min read
FDA
Recordati Rare Diseases Inc. Announces Availability of ISTURISA® (osilodrostat) in the United States
May 27, 2020
 · 
8 min read
FDA
FDA Approves Only Drug in U.S. to Treat Severe Malaria
May 26, 2020
 · 
3 min read
FDA
FDA Approves First Treatment for a Form of Bladder Dysfunction in Pediatric Patients as Young as 2 Years of Age
May 26, 2020
 · 
4 min read
FDA
FDA Approves Dupixent® (dupilumab) as First Biologic Medicine for Children Aged 6 to 11 Years with Moderate-to-Severe Atopic Dermatitis
May 26, 2020
 · 
23 min read
FDA
Expression Therapeutics Announces IND Approval by the FDA for Hemophilia A Gene Therapy
May 26, 2020
 · 
2 min read
FDA
CytRx Corporation Highlights Orphazyme’s Receipt of FDA Fast Track Designation for the Development of Arimoclomol in Amyotrophic Lateral Sclerosis (ALS)
May 26, 2020
 · 
4 min read
FDA
Sorrento Receives FDA IND Clearance to Initiate a Phase I Clinical Trial of its CD38 Antibody-Drug Conjugate (ADC) STI-6129 for Patients with Amyloidosis
May 26, 2020
 · 
5 min read
Load More